Tag: Pf Magazine January 2019
Latest articles
NICE to work with GW Pharma on cannabidiol evaluation
NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...
NHS Spine marks five-year anniversary
NHS Spine is marking five years since it was brought in house by NHS Digital and run as an open source service for the...
Cyber threats in healthcare: What are the risks?
FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...
Popular articles
Positive phase III study results for injectable HIV-treatment regimen
ViiV Healthcare has announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV...
Gedeon Richter’s biosimilar for osteoporosis available on NHS
Gedeon Richter has announced that its biosimilar for osteoporosis, Terrosa® (teriparatide), is available on the NHS for the treatment of osteoporosis in postmenopausal women...
Cyber threats in healthcare: What are the risks?
FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...
NHS England makes Roche’s Hemlibra® available on NHS
NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
NICE to work with GW Pharma on cannabidiol evaluation
NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...